HA
CVS icon

Harfst & Associates’s CVS Health CVS Stock Holding History

Harfst & Associates’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,898
Closed -$231K – 105
2024
Q1 		$231K Sell
2,898
-47
-2% -$3.59K 0.05% 102
2023
Q4 		$233K Hold
2,945
– – 0.06% 84
2023
Q3 		$206K Sell
2,945
-58
-2% -$4.11K 0.06% 87
2023
Q2 		$208K Sell
3,003
-4,769
-61% -$339K 0.06% 89
2023
Q1 		$578K Buy
7,772
+6
+0.1% +$503 0.17% 84
2022
Q4 		$724K Sell
7,766
-120
-2% -$11.6K 0.21% 70
2022
Q3 		$752K Sell
7,886
-412
-5% -$40.8K 0.23% 68
2022
Q2 		$768K Sell
8,298
-2,726
-25% -$266K 0.22% 69
2022
Q1 		$1.11M Buy
11,024
+1,199
+12% +$126K 0.26% 67
2021
Q4 		$1.01M Sell
9,825
-600
-6% -$55.4K 0.26% 64
2021
Q3 		$884K Buy
10,425
+20
+0.2% +$1.68K 0.24% 71
2021
Q2 		$868K Sell
10,405
-1,141
-10% -$93.4K 0.25% 74
2021
Q1 		$868K Buy
11,546
+5,453
+89% +$397K 0.26% 76
2020
Q4 		$416K Buy
6,093
+1,189
+24% +$77.3K 0.15% 93
2020
Q3 		$286K Buy
4,904
+216
+5% +$13.4K 0.12% 102
2020
Q2 		$304K Buy
4,688
+35
+0.8% +$2.2K 0.13% 83
2020
Q1 		$276K Sell
4,653
-1
-0% -$67 0.14% 81
2019
Q4 		$345K Sell
4,654
-76
-2% -$5.34K 0.13% 76
2019
Q3 		$298K Buy
+4,730
New +$280K 0.12% 78

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Harfst & Associates's CVS Position: Q2 2024 in Review

Harfst & Associates sold out of CVS Health (CVS) in Q2 2024, closing a stake of 2,898 shares — an estimated $231K sold.

Harfst & Associates first reported a position in CVS in Q3 2019 and held it in 19 quarters. The position peaked at $1.11M in Q1 2022. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • Harfst & Associates reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • Harfst & Associates sold 2,898 CVS Health shares in Q2 2024, an estimated $231K.
  • Harfst & Associates first reported a position in CVS Health in Q3 2019 and held it in 19 quarters.
  • Harfst & Associates's CVS Health position peaked at $1.11M in Q1 2022.
  • 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Harfst & Associates's 13F filing for Q2 2024, filed 1 Aug 2024.